Unraveling the Role of microRNAs in the Metastatic Landscape of Gastric Cancer
DOI:
https://doi.org/10.62382/jcbt.v2i1.44Keywords:
Gastric cancer, MicroRNAs, Metastasis, Tumor microenvironment, Oncogenes, Tumor suppressorsAbstract
Gastric cancer (GC) continues to pose a major health issue worldwide, and diagnoses made at advanced stages frequently result in unfavorable outcomes. The metastatic spread of GC presents substantial therapeutic challenges, necessitating a deeper understanding of the tumor microenvironment (TME) and its interactions with cancer cells. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression and have been identified as key factors in the metastasis of GC. This review explores the biogenesis and functional mechanisms of miRNAs, highlighting their dual roles as oncogenes and tumor suppressors in GC metastasis. We discuss specific miRNAs that facilitate metastatic progression by influencing key pathways related to invasion, angiogenesis, and immune evasion. Furthermore, we examine the potential of miRNAs as diagnostic and prognostic biomarkers, offering insights into their utility in timely identification and tailored therapeutic approaches. By elucidating the complex regulatory networks involving miRNAs, this review underscores their significance as both therapeutic targets and biomarkers in the management of gastric cancer.
Downloads
References
Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences. 2020, 21(11), 4012.
Deng H, Gao J, Cao B, Qiu Z, Li T, et al. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cellular Oncology (Dordrecht Netherlands). 2023, 46(6), 1675-1690.
Duda D, Dima S, Sorop A, Kitahara S, Setia N, et al. A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment. Research Square. 2023, rs.3.rs-3089359.
Li H, Cao B, Zhao R, Li T, Xu X, et al. circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis. Frontiers in Oncology. 2022, 12, 817192.
Mei Y, Feng X, Feng T, Yan M, Zhu Z, et al. Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study. Frontiers in Pharmacology. 2022, 13, 845261.
Jorge AL, Pereira ER, Oliveira CS, Ferreira EDS, Menon ETN, et al. MicroRNAs: understanding their role in gene expression and cancer. Einstein (Sao Paulo Brazil). 2021, 19, eRB5996.
Gharakhyli EA, Tabar Molla Hassan A, Alipour M, Vahidi S, Samadani AA. The effect of miR-372-5p regulation on CDX1 and CDX2 in the gastric cancer cell line. Hormone Molecular Biology and Clinical Investigation. 2023, 44(3), 271-276.
Wu X, Yan F, Wang L, Sun G, Liu J, et al. MicroRNA: Another Pharmacological Avenue for Colorectal Cancer? Frontiers in Cell and Developmental Biology. 2020, 8, 812.
O'Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology. 2018, 9, 402.
Guo Q, Li D, Luo X, Yuan Y, Li T, et al. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer. Frontiers in Immunology. 2021, 12, 684807.
Zhao X, Xiao Z, Li B, Li H, Yang B, et al. miRNA-21 may serve as a promising noninvasive marker of glioma with a high diagnostic performance: a pooled analysis of 997 patients. Therapeutic Advances in Medical Oncology. 2021, 13, 1758835920987650.
Annese T, Tamma R, De Giorgis M, Ribatti D. microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis. Frontiers in Oncology. 2020, 10, 581007.
Kretov DA, Walawalkar IA, Mora-Martin A, Shafik AM, Moxon S, et al. Ago2-Dependent Processing Allows miR-451 to Evade the Global MicroRNA Turnover Elicited during Erythropoiesis. Molecular Cell. 2020, 78(2), 317-328.e6.
Butkytė S, Čiupas L, Jakubauskienė E, Vilys L, Mocevicius P, et al. Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells. Clinical Epigenetics. 2016, 8, 33.
Xie M, Li M, Vilborg A, Lee N, Shu MD, et al. Mammalian 5'-capped microRNA precursors that generate a single microRNA. Cell. 2013, 155(7), 1568-80.
Datta N, Johnson C, Kao D, Gurnani P, Alexander C, et al. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacological Research. 2023, 194, 106870.
Pekarek L, Torres-Carranza D, Fraile-Martinez O, García-Montero C, Pekarek T, et al. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis. International Journal of Molecular Sciences. 2023, 24(8), 7268.
Huang D, Duan H, Huang H, Tong X, Han Y, et al. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Scientific Reports. 2016, 6, 20502.
Ruggieri V, Russi S, Zoppoli P, La Rocca F, Angrisano T, et al. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. Journal of Clinical Medicine. 2019, 8(5), 639.
Shi X, Wang X, Yao W, Shi D, Shao X, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduction and Targeted Therapy. 2024, 9(1), 192.
Mirzajani E, Vahidi S, Norollahi SE, Samadani AA. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment. Microrna. 2022, 11(1), 12-24.
Wang N, Tan HY, Feng YG, Zhang C, Chen F, et al. microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance. Cancers (Basel). 2018, 11(1), 7.
Jiang Z, Chen H, Su M, Wu L, Yu X, et al. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis. Bioengineered. 2021, 12(2), 11277-11287.
Jiang LH, Zhang HD, Tang JH. MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer. Journal of Oncology. 2018, 2018, 5167829.
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, et al. The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics. Molecular Therapy Nucleic Acids. 2020, 20, 409-420.
Peralta-Zaragoza O, Deas J, Meneses-Acosta A, De la OGF, Fernández-Tilapa G, et al. Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells. BMC Cancer. 2016, 16, 215.
Ge Y, Shu J, Shi G, Yan F, Li Y, et al. miR-100 Suppresses the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells via Targeting CXCR7. Journal of Immunology Research. 2021, 2021, 9920786.
Peng CW, Yue LX, Zhou YQ, Tang S, Kan C, et al. miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2. Cancer Cell International. 2019, 19, 354.
Yu X, Zhang Y, Luo F, Zhou Q, Zhu L. The role of microRNAs in the gastric cancer tumor microenvironment. Molecular Cancer. 2024, 23(1), 170.
Wu Q, Yang Z, An Y, Hu H, Yin J, et al. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell Death and Disease. 2014, 5(3), e1144.
Touchaei AZ, Vahidi S, Samadani AA. Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy. Medical Oncology. 2023, 41(1), 21.
Fang LL, Wang XH, Sun BF, Zhang XD, Zhu XH, et al. Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review). International Journal of Molecular Medicine. 2017, 40(6), 1624-1630.
Lloyd KA, Moore AR, Parsons BN, O'Hara A, Boyce M, et al. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1. Oncotarget. 2016, 7(29), 45462-45478.
Wang Y, Li Z, Zhao X, Zuo X, Peng Z. miR-10b promotes invasion by targeting HOXD10 in colorectal cancer. Oncology Letters. 2016, 12(1), 488-494.
Shi J, Zhang Y, Jin N, Li Y, Wu S, et al. MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression. Oncology Research. 2017, 25(4), 523-536.
Shah JA, Khattak S, Rauf MA, Cai Y, Jin J. Potential Biomarkers of miR-371-373 Gene Cluster in Tumorigenesis. Life (Basel). 2021, 11(9), 984.
Yang L, Li L, Chang P, Wei M, Chen J, et al. miR-25 Regulates Gastric Cancer Cell Growth and Apoptosis by Targeting EGR2. Frontiers in Genetics. 2021, 12, 690196.
Khalilian S, Hosseini Imani SZ, Ghafouri-Fard S. Emerging roles and mechanisms of miR-206 in human disorders: a comprehensive review. Cancer Cell International. 2022, 22(1), 412.
Fu J, Imani S, Wu MY, Wu RC. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential. Cancers (Basel). 2023, 15(19), 4723.
Gao W, Zhou J, Morshedi M. MicroRNA-34 and gastrointestinal cancers: a player with big functions. Cancer Cell International. 2024, 24(1), 163.
Sawant D, Lilly B. MicroRNA-145 targets in cancer and the cardiovascular system: evidence for common signaling pathways. Vascular Biology. 2020, 2(1), R115-R128.
Lin C, Huang F, Li QZ, Zhang YJ. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. International Journal of Clinical and Experimental Pathology. 2014, 7(10), 6543-50.
Luo C, Zhang J, Zhang Y, Zhang X, Chen Y, et al. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma. Cell Cycle. 2020, 19(15), 1983-1993.
Shen ZY, Zhang ZZ, Liu H, Zhao EH, Cao H. miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Experimental and Therapeutic Medicine. 2014, 7(6), 1757-1761.
Deng M, Qin Y, Chen X, Wang Q, Wang J. MiR-206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the MUC1 gene. OncoTargets and Therapy. 2019, 12, 849-859.
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B, et al. MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell International. 2013, 13(1), 68.
Li X, Li L, Wu J. The members of the miR-148/152 family inhibit cancer stem cell-like properties in gastric cancer via negative regulation of ITGA5. Journal of Translational Medicine. 2023, 21(1), 105.
Zhang X, Shi H, Tang H, Fang Z, Wang J, et al. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. International Journal of Molecular Medicine. 2015, 35(5), 1301-8.
Li Z, Li D, Zhang G, Xiong J, Jie Z, et al. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer. American Journal of Cancer Research. 2014, 4(6), 648-62.
Xie W, Wang Z, Wang J, Wang X, Guan H. Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review). International Journal of Oncology. 2024, 65(1), 67.
Zhou R, Zhou X, Yin Z, Guo J, Hu T, et al. MicroRNA-574-5p promotes metastasis of non-small cell lung cancer by targeting PTPRU. Scientific Reports. 2016, 6, 35714.
Li Y, Zhou HC, Zhang Y, Huang H. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2. European Review for Medical and Pharmacological Sciences. 2020, 24(3), 1177-1185.
Liu Q, Cheng C, Huang J, Yan W, Wen Y, et al. MYH9: A key protein involved in tumor progression and virus-related diseases. Biomedicine & Pharmacotherapy. 2024, 171, 116118.
Liang S, He L, Zhao X, Miao Y, Gu Y, et al. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One. 2011, 6(4), e18409.
Zhao X, Dou W, He L, Liang S, Tie J, et al. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene. 2013, 32(11), 1363-72.
Suyal G, Pandey P, Saraya A, Sharma R. Tumour suppressor role of microRNA-335-5p in esophageal squamous cell carcinoma by targeting TTK (Mps1). Experimental and Molecular Pathology. 2022, 124, 104738.
Wang GJ, Jiao BP, Liu YJ, Li YR, Deng BB. Reactivation of microRNA-506 inhibits gastric carcinoma cell metastasis through ZEB2. Aging. 2019, 11(6), 1821-1831.
Wang S, Wu Y, Yang S, Liu X, Lu Y, et al. miR-874 directly targets AQP3 to inhibit cell proliferation, mobility and EMT in non-small cell lung cancer. Thoracic Cancer. 2020, 11(6), 1550-1558.
Gao D, Zhou Z, Huang H. miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway. Frontiers in Genetics. 2019, 10, 1274.
Li WJ, Wang Y, Liu R, Kasinski AL, Shen H, et al. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic. Frontiers in Cell and Developmental Biology. 2021, 9, 640587.
Ye L, Wang F, Wu H, Yang H, Yang Y, et al. Functions and Targets of miR-335 in Cancer. OncoTargets and Therapy. 2021, 14, 3335-3349.
Jelski W, Mroczko B. Potential Diagnostic Utility of microRNAs in Gastrointestinal Cancers. Cancer Management and Research. 2023, 15, 863-871.
Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, et al. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells. 2020, 9(2), 276.
Aziz F, Chakraborty A, Khan I, Monts J. Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer. Biology. 2022, 11(2), 249.
Qin Y, Liang R, Lu P, Lai L, Zhu X. Depicting the Implication of miR-378a in Cancers. Technology in Cancer Research and Treatment. 2022, 21, 15330338221134385.
Xu Y, Wang G, Hu W, He S, Li D, et al. Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients: A meta-analysis. Medicine (Baltimore). 2022, 101(19), e29242.
Shao Y, Geng Y, Gu W, Huang J, Ning Z, et al. Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis. Disease Markers. 2014, 2014, 626185.
Baran K, Kordiak J, Jabłoński S, Antczak A, Brzeziańska-Lasota E. The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC. Journal of Clinical Medicine. 2022, 11(3), 655.
Garrido-Cano I, Pattanayak B, Adam-Artigues A, Lameirinhas A, Torres-Ruiz S, et al. MicroRNAs as a clue to overcome breast cancer treatment resistance. Cancer and Metastasis Reviews. 2022, 41(1), 77-105.
Wu SR, Wu Q, Shi YQ. Recent advances of miRNAs in the development and clinical application of gastric cancer. Chinese Medical Journal. 2020, 133(15), 1856-1867.
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, et al. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncology Reports. 2012, 27(4), 1019-26.
Shekari N, Baradaran B, Shanehbandi D, Kazemi T. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer. Current Medicinal Chemistry. 2018, 25(6), 698-714.
Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clinical significance of miR-146a in gastric cancer cases. Clinical Cancer Research. 2011, 17(13), 4277-84.
Li X, Tibenda JJ, Nan Y, Huang SC, Ning N, et al. MiR-204-3p overexpression inhibits gastric carcinoma cell proliferation by inhibiting the MAPK pathway and RIP1/MLK1 necroptosis pathway to promote apoptosis. World Journal of Gastroenterology. 2023, 29(29), 4542-4556.
Chen B, Guo S, Yu Z, Feng Y, Hui L. Downregulation of microRNA-375, combined with upregulation of its target gene Janus kinase 2, predicts unfavorable prognosis in patients with gastric cancer. International Journal of Clinical and Experimental Pathology. 2017, 10(11), 11106-11113.
Ma Y, Shen N, Wicha MS, Luo M. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. Cells. 2021, 10(9), 2415.
Deng M, Zeng C, Lu X, He X, Zhang R, et al. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Letters. 2017, 403, 175-185.
Zhang Y, Wen X, Hu XL, Cheng LZ, Yu JY, et al. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. European Review for Medical and Pharmacological Sciences. 2016, 20(14), 3026-30.
Chakrabortty A, Patton DJ, Smith BF, Agarwal P. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer. Genes (Basel). 2023, 14(7), 1375.
Liu H, Wang L. MicroRNA-34a negatively regulates Netrin1 and mediates MEK/ERK pathway to regulate chemosensitivity of gastric cancer cells. Discover Oncology. 2024, 15(1), 563.
Zhou M, Wu Y, Li H, Zha X. MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers. Journal of Cancer. 2020, 11(22), 6716-6726.
Ma G, Dai W, Sang A, Yang X, Gao C. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. International Journal of Clinical and Experimental Pathology. 2014, 7(12), 8833-40.
Cao Y, Song J, Ge J, Song Z, Chen J, et al. MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7. Oncology Letters. 2018, 15(1), 453-458.
Bian LH, Duan JL, Zhou C, Shen GW, Wang XY, et al. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells. Molecular Medicine Reports. 2020, 22(1), 51-56.
Podralska M, Ciesielska S, Kluiver J, van den Berg A, Dzikiewicz-Krawczyk A, et al. Non-Coding RNAs in Cancer Radiosensitivity: MicroRNAs and lncRNAs as Regulators of Radiation-Induced Signaling Pathways. Cancers (Basel). 2020, 12(6), 1662.
Halimi M, Shahabi A, Moslemi D, Parsian H, Asghari SM, et al. Human serum miR-34a as an indicator of exposure to ionizing radiation. Radiation and Environmental Biophysics. 2016, 55(4), 423-429.
Hamama S, Noman MZ, Gervaz P, Delanian S, Vozenin MC. MiR-210: A potential therapeutic target against radiation-induced enteropathy. Radiotherapy and Oncology. 2014, 111(2), 219-21.
Pedroza-Torres A, Romero-Córdoba SL, Montaño S, Peralta-Zaragoza O, Vélez-Uriza DE, et al. Radio-miRs: a comprehensive view of radioresistance-related microRNAs. Genetics. 2024, 227(4).
Nail HM, Chiu CC, Leung CH, Ahmed MMM, Wang HD. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. Journal of Biomedical Science. 2023, 30(1), 69.
Szatmári T, Hargitai R, Sáfrány G, Lumniczky K. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation. International Journal of Molecular Sciences. 2019, 20(22), 5527.
Nguyen L, Schilling D, Dobiasch S, Raulefs S, Santiago Franco M, et al. The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer. Cancers (Basel). 2020, 12(12), 3703.
Huang J, He Y, McLeod HL, Xie Y, Xiao D, et al. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer. BMC Cancer. 2017, 17(1), 886.
Hu X, Wang Y, Liang H, Fan Q, Zhu R, et al. miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer. Cell Death and Disease. 2017, 8(10), e3059.
Ye D, Shen Z, Zhou S. Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment. Cancer Management and Research. 2019, 11, 969-979.
Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, et al. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel). 2021, 10(5), 417.
Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 2010, 16(8), 909-14.
Si Y, Zhang H, Ning T, Bai M, Wang Y, et al. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma. Cellular Physiology and Biochemistry. 2017, 42(4), 1670-1683.
Zhang J, Zhang J, Pang X, Chen Z, Zhang Z, et al. MiR-205-5p suppresses angiogenesis in gastric cancer by downregulating the expression of VEGFA and FGF1. Experimental Cell Research. 2021, 404(2), 112579.
Yu B, Zhu N, Fan Z, Li J, Kang Y, et al. miR-29c inhibits metastasis of gastric cancer cells by targeting VEGFA. Journal of Cancer. 2022, 13(14), 3566-3574.
Zou C, Xu Q, Mao F, Li D, Bian C, et al. MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle. 2012, 11(11), 2137-45.
Zhang X, Tang J, Zhi X, Xie K, Wang W, et al. miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget. 2015, 6(3), 1605-17.
Zhang R, Miao Z, Liu Y, Zhang X, Yang Q. A positive feedback loop between miR-574-3p and HIF-1α in promoting angiogenesis under hypoxia. Microvascular Research. 2023, 150, 104589.
Lian M, Mortoglou M, Uysal-Onganer P. Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer. Current Issues in Molecular Biology. 2023, 45(12), 9778-9792.
Wang L, Bo X, Zheng Q, Ge W, Liu Y, et al. Paired box 8 suppresses tumor angiogenesis and metastasis in gastric cancer through repression of FOXM1 via induction of microRNA-612. Journal of Experimental & Clinical Cancer Research. 2018, 37(1), 159.
Orso F, Quirico L, Dettori D, Coppo R, Virga F, et al. Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Seminars in Cancer Biology. 2020, 60, 214-224.
Zabeti Touchaei A, Vahidi S. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways. Cancer Cell International. 2024, 24(1), 102.
Chen CW, Wang HC, Tsai IM, Chen IS, Chen CJ, et al. CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression. Cancer Immunology, Immunotherapy. 2024, 73(1), 1.
Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, et al. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacological Research. 2023, 187, 106568.
Zhihua Y, Yulin T, Yibo W, Wei D, Yin C, et al. Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer. Cancer Science. 2019, 110(8), 2368-2377.
Li J, Ju J, Ni B, Wang H. The emerging role of miR-506 in cancer. Oncotarget. 2016, 7(38), 62778-62788.
Du J, Liang Y, Li J, Zhao JM, Lin XY. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN. Frontiers in Oncology. 2020, 10, 326.
Wu ZH, Lin C, Liu CC, Jiang WW, Huang MZ, et al. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway. Biochemical and Biophysical Research Communications. 2018, 501(4), 1068-1073.
Yang X, Cai S, Shu Y, Deng X, Zhang Y, et al. Exosomal miR-487a derived from m2 macrophage promotes the progression of gastric cancer. Cell Cycle. 2021, 20(4), 434-444.
Wang S, Li Y, Xing C, Ding C, Zhang H, et al. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer. American Journal of Cancer Research. 2020, 10(7), 1937-1953.
Babar Q, Saeed A, Tabish TA, Sarwar M, Thorat ND. Targeting the tumor microenvironment: Potential strategy for cancer therapeutics. Biochimica et Biophysica Acta: Molecular Basis of Disease. 2023, 1869(6), 166746.
Li J, Sun J, Zeng Z, Liu Z, Ma M, et al. Tumour-associated macrophages in gastric cancer: From function and mechanism to application. Clinical and Translational Medicine. 2023, 13(8), e1386.
Sheedy FJ. Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response. Frontiers in Immunology. 2015, 6, 19.
Cui HY, Rong JS, Chen J, Guo J, Zhu JQ, et al. Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells. World Journal of Gastroenterology. 2021, 27(36), 6079-6092.
Wang B, Zhang Z, Liu W, Tan B. Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis. Biomedicine & Pharmacotherapy. 2023, 158, 114180.
Wang L, Wang E, Wang Y, Mines R, Xiang K, et al. miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis. Elife. 2018, 7, e39479.
Taheri F, Ebrahimi SO, Shareef S, Reiisi S. Regulatory and immunomodulatory role of miR-34a in T cell immunity. Life Sciences. 2020, 262, 118209.
Hu W, Zheng X, Liu J, Zhang M, Liang Y, et al. MicroRNA MiR-130a-3p promotes gastric cancer by targeting Glucosaminyl N-acetyl transferase 4 (GCNT4) to regulate the TGF-β1/SMAD3 pathway. Bioengineered. 2021, 12(2), 11634-11647.
Ren W, Zhang X, Li W, Feng Q, Feng H, et al. Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer. Cancer Management and Research. 2019, 11, 4023-4040.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Cancer Biomoleculars and Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
